Latest KFF Health News Stories
En más estados, médicos recetan opioides junto con droga para revertir sobredosis
Dos millones de estadounidenses son adictos a los analgésicos recetados, según la FDA. Y casi 218,000 personas murieron por sobredosis de 1999 a 2017, según los CDC.
More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.
El alto costo del sexo: aseguradoras no pagan por drogas para resolver problemas
Medicare y aseguradoras privadas suelen no pagar los costos de medicamentos que ayudan a superar disfunciones sexuales comunes en adultos mayores.
The High Cost Of Sex: Insurers Often Don’t Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that’s not medically necessary to pay for.
Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ For Dummies
The “Medicare–for-all” debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner for a beginner’s guide to the next big health policy debate. For “extra credit,” the panelists provide their favorite health policy stories of the week, and as a special Valentine’s Day bonus, their favorite #HealthPolicyValentines.
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
False Lead: Senator’s Offer To Help Patient Import Cheap Insulin Goes Nowhere
Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesn’t appear to exist.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Drug-Pricing Policies Find New Momentum As ‘A 2020 Thing’
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Extreme Temperatures May Pose Risks To Some Mail-Order Meds
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
